The real breakthrough isn't just using better AI models, but in giving those models deep, structured understanding of how an organization functions, making reliable detection and automated response possible.
No one wants to write a shitty code base. You want healthy code. And so, what founders don't realize is, when you're not taking care of your health, you are shitty code. You are not beautiful code.
Cursor is nearing a funding round of at least $2 billion, with returning investors Thrive and Andreessen Horowitz expected to lead the financing at a $50 billion valuation. The deal terms are not final and may still change.
Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.
Awards may be encouraging and occasionally useful for visibility, but they are weak indicators of validation and poor predictors of long-term success. In the longevity and healthspan industry, where timelines are long and claims are easy to overstate, venture capital ultimately follows alignment and evidence, not applause received at glitzy industry events.
Raising venture capital too early can cost you control, leverage and even your company. Early capital is often highly dilutive, selling off your future before your blueprint is complete. The difference between lighting a spark and burning your equity to ash is a lesson many founders learn too late.
Because startups typically don't have a track record of success to attract potential clients, they can offer a trial of their platform for free or at a lower cost to showcase what their platform can do and how reliable it is. The enterprise - a potential client - can test the newest technologies without the worry of committing to a complete and often costly rollout.
In an era obsessed with shortcuts, overnight success, and polished social media profiles, adversity is often treated as something to avoid. Something unfortunate. Something that signals failure. That assumption is completely wrong. Adversity is not a flaw in the entrepreneurial journey; it is, in fact, the training ground, the pressure that sharpens one's judgment, accelerates their adaptability and forges the kind of resilience no accelerator, MBA or funding round can manufacture.